JB, K., MJ, A., RT, M., BE, J., TM, R., & GM, B. (1989). Plasma-derived versus recombinant hepatitis B vaccines. Lancet (London, England), 1(8635), 451. https://doi.org/10.1016/s0140-6736(89)90057-3
Chicago Style (17th ed.) CitationJB, Kurtz, Alder MJ, Mayon-White RT, Juel-Jensen BE, Rodgers TM, and Babic GM. "Plasma-derived Versus Recombinant Hepatitis B Vaccines." Lancet (London, England) 1, no. 8635 (1989): 451. https://doi.org/10.1016/s0140-6736(89)90057-3.
MLA (9th ed.) CitationJB, Kurtz, et al. "Plasma-derived Versus Recombinant Hepatitis B Vaccines." Lancet (London, England), vol. 1, no. 8635, 1989, p. 451, https://doi.org/10.1016/s0140-6736(89)90057-3.
Warning: These citations may not always be 100% accurate.